Kaiohm - a significant rebound, reached a basic agreement on business partnership with Kids Well Bio for the development of biosimilar pharmaceuticals.

Fisco Japan · Jun 18 20:14

Significantly rebounded. Kidswell Bio <4584> announced the conclusion of a basic agreement on business partnership related to the development of biosimilar pharmaceuticals. Both companies will share their experience and know-how in the development of biopharmaceuticals they hold, as well as sharing the costs related to development investment. The revenue obtained by transferring or licensing cell strains and manufacturing processes developed through the cooperation of both companies to pharmaceutical companies will be profit shared by both companies, aiming to establish a new source of revenue.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

カイオム---大幅に反発、キッズウェル・バイオとバイオシミラー医薬品開発の業務提携で基本合意

Kaiohm - a significant rebound, reached a basic agreement on business partnership with Kids Well Bio for the development of biosimilar pharmaceuticals.

Risk Disclaimer

Statement